KI
HAE icon

Koch Industries’s Haemonetics HAE Stock Holding History

Koch Industries’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-4,422
Closed -$324K – 271
2018
Q1 		$324K Sell
4,422
-3,860
-47% -$265K 0.03% 604
2017
Q4 		$481K Buy
8,282
+1,392
+20% +$73.3K 0.07% 250
2017
Q3 		$310K Buy
+6,890
New +$286K 0.07% 291

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Koch Industries's HAE Position: Q2 2018 in Review

Koch Industries sold out of Haemonetics (HAE) in Q2 2018, closing a stake of 4,422 shares — an estimated $324K sold.

Koch Industries first reported a position in HAE in Q3 2017 and held it in 3 quarters. The position peaked at $481K in Q4 2017. 293 funds tracked by Wall St. Rank hold HAE as of Q2 2018.

  • Koch Industries reported no remaining Haemonetics position as of Q2 2018 after selling out during the quarter.
  • Koch Industries sold 4,422 Haemonetics shares in Q2 2018, an estimated $324K.
  • Koch Industries first reported a position in Haemonetics in Q3 2017 and held it in 3 quarters.
  • Koch Industries's Haemonetics position peaked at $481K in Q4 2017.
  • 293 funds tracked by Wall St. Rank held Haemonetics as of Q2 2018.

Based on Koch Industries's 13F filing for Q2 2018, filed 13 Aug 2018.